News
4317 posts · page 47 of 180
Mapping Molecular Diagnostics for WHO Priority Pathogens
A new study maps diagnostic platforms and resistance markers to tackle WHO's priority bacterial pathogens.
Medtronic Raises Fiscal 2027 Outlook Amid Heart Device Demand
Medtronic boosts fiscal 2027 forecasts, driven by strong demand for heart devices and strategic investments.
Molbio Diagnostics Reports Rs 52.7 Cr Profit in Q1 After IPO
Molbio Diagnostics achieves Rs 52.7 crore profit in Q1, reversing last year's loss, driven by robust Truenat test-kit sales.
Dr. Paul Russell, Trailblazer in Organ Transplants, Dies at 101
Dr. Paul Russell, who pioneered safe organ transplants, has passed away at 101. His work revolutionized transplant surgery.
Medtronic Elevates 2027 Forecast Amid Surging Heart Device Demand
Medtronic boosts fiscal 2027 outlook, fueled by rising demand for heart devices and strategic investments.
Molbio Diagnostics Sees Rs 52.7 Cr Profit in Q1 After IPO Success
Molbio Diagnostics posts Rs 52.7 crore profit in Q1, reversing last year's loss, driven by Truenat test-kit sales.
Dr. Paul Russell, Renowned Transplant Surgeon, Dies at 101
Dr. Paul Russell, a pioneering figure in organ transplantation, has died at age 101. His groundbreaking work made transplants safer and more effective.
Medtronic Raises 2027 Forecasts Amid Surging Heart Device Demand
Medtronic elevates fiscal 2027 forecasts, driven by robust heart device demand and strategic investments.
Molbio Diagnostics Reports Rs 52.7 Crore Profit in Q1 After IPO
Molbio Diagnostics posts Rs 52.7 crore profit in Q1, reversing last year's Rs 23.94 crore loss.
Dr. Paul Russell, Trailblazer in Organ Transplants, Dies at 101
Dr. Paul Russell, a pioneer in organ transplantation, passed away at 101. His groundbreaking work in kidney transplants saved numerous lives.
Medtronic Raises 2027 Forecasts Amid Strong Heart Device Demand
Medtronic increases fiscal 2027 revenue outlook, citing robust demand for heart devices and strategic investments.
Molbio Diagnostics Reports Rs 52.7 Crore Profit in Q1 After IPO Success
Molbio Diagnostics posted a Rs 52.7 crore profit in Q1, driven by Truenat test-kit sales, following its recent IPO.
Renowned Transplant Surgeon Dr. Paul Russell Passes Away at 101
Dr. Paul Russell, a pioneer in organ transplantation, dies at 101. His groundbreaking work saved countless lives.
Medtronic Raises 2027 Revenue Forecast Amid Heart Device Surge
Medtronic ups 2027 revenue outlook, driven by strong demand for heart devices and strategic investments.
Molbio Diagnostics Reports Rs 52.7 Crore Profit in First Quarter Post-IPO
Molbio Diagnostics, newly listed on the stock exchange, has announced a profit of Rs 52.74 crore for Q1, reversing a loss from the previous year.
Dr. Paul Russell, Renowned Transplant Surgeon, Passes Away at 101
Dr. Paul Russell, a trailblazer in organ transplantation, has died at 101. His pioneering work in the field saved countless lives.
Medtronic Raises 2027 Outlook Amid Rising Heart Device Demand
Medtronic ups fiscal 2027 forecasts, driven by strong demand for cardiovascular devices.
Molbio Diagnostics Reports Rs 52.7 Crore Profit in Q1 Post-IPO
Molbio Diagnostics, fresh from its IPO, posts Rs 52.74 crore profit in Q1, reversing last year's loss.
Dr. Paul Russell, Renowned Transplant Surgeon, Passes Away at 101
Dr. Paul Russell, a pioneering figure in organ transplant surgery, has died at 101, leaving a legacy of innovation in medical science.
Medtronic Raises 2027 Forecasts Amid Surge in Heart Device Demand
Medtronic boosts its fiscal 2027 outlook, driven by strong demand for heart devices and strategic investments.
Molbio Diagnostics Reports Rs 52.7 Crore Q1 Profit, Reverses Previous Loss
Molbio Diagnostics achieved a Rs 52.7 crore profit in Q1, reversing last year's loss, driven by increased Truenat test-kit sales.
Dr. Paul Russell, Pioneer in Organ Transplants, Passes at 101
Dr. Paul Russell, a trailblazer in organ transplant surgery, died at 101. His 1963 kidney transplant marked a turning point in medical history.
Medtronic Raises Fiscal 2027 Outlook Amid Heart Device Demand Surge
Medtronic ups fiscal 2027 revenue forecast, driven by increased demand for heart devices and strategic investments.
Molbio Diagnostics Reports Rs 52.7 Crore Profit in Q1 Post-IPO
Molbio Diagnostics turned a profit of Rs 52.74 crore in Q1, a significant recovery from last year's loss.